DI BELLA METHOD > DOCUMENTATION INDEX > MDB - Documents

 
 
MDB - Documents
 
 
Terminal differentiation of human promyelocytic leukaemia cells, HL-60, during the G1 period. (22/05/2003)
Detail
Vitamin D receptor genotype and breast cancer in Latinas (United States). (22/05/2003)
Detail
Will analogs of 1,25-dihydroxyvitamin D(3) (calcitriol) open a new era in cancer therapy? (22/05/2003)
Detail
Vitamin D analogs in cutaneous malignancies. (22/05/2003)
Detail
Human leukemic (HMC-1) mast cells are responsive to 1alpha, 25-dihydroxyvitamin D(3): selective promotion of ICAM-3 expression and constitutive presence of vitamin D(3) receptor. (22/05/2003)
Detail
24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation. (22/05/2003)
Detail
25-Hydroxyvitamin D(3)-1alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. (22/05/2003)
Detail
1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms. (22/05/2003)
Detail
1,25(OH)2 vitamin D3 induces elevated expression of the cell cycle-regulating genes P21 and P27 in squamous carcinoma cell lines of the head and neck. (22/05/2003)
Detail
1,25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration. (22/05/2003)
Detail
Insulin-like growth factor binding protein-3 mediates 1 alpha,25-dihydroxyvitamin d(3) growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1. (22/05/2003)
Detail
The effects of 1alpha,24(S)-dihydroxyvitamin D(2) analog on cancer cell proliferation and cytokine expression. (22/05/2003)
Detail
Parathyroid hormone may be a cancer promoter - an explanation for the decrease in cancer risk associated with ultraviolet light, calcium, and vitamin D. (22/05/2003)
Detail
Amphiregulin is a vitamin D3 target gene in squamous cell and breast carcinoma. (22/05/2003)
Detail
Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. (22/05/2003)
Detail
 
 
 
Scorri con le frecce per visualizzare le pagine della ricerca 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 |
 
 

Stampa